The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cetuximab or Panitumumab versus Bevacizumab in the treatment of first line RAS wild type colorectal cancer: pooled analysis of randomized clinical trials.
 
Emiliano Tamburini
No Relationships to Disclose
 
Britt Rudnas
No Relationships to Disclose
 
Mario Nicolini
No Relationships to Disclose
 
Stefania Nicoletti
No Relationships to Disclose
 
Manuela Fantini
No Relationships to Disclose
 
Claudio Ridolfi
No Relationships to Disclose
 
Carlotta Santelmo
No Relationships to Disclose
 
Lucia Stocchi
No Relationships to Disclose
 
Paolo Fabbri
No Relationships to Disclose
 
Eleonora Barzotti
No Relationships to Disclose
 
Fabrizio Drudi
No Relationships to Disclose
 
Maximilian Papi
No Relationships to Disclose
 
Lorenzo Gianni
No Relationships to Disclose
 
Davide Tassinari
No Relationships to Disclose